National Development and Reform Commission or cut the price adjustment range of traditional Chinese medicine within the year from 10% to 20%

There are rumors of drug prices falling again Yesterday, it was reported that the price department of the national development and Reform Commission would reduce the price of traditional Chinese medicine by the end of this year The list of low-cost drugs is also expected to be released this year The national development and Reform Commission may cancel the original maximum retail price, and change it to be priced by the manufacturers within the daily use fee range, so as to encourage the enterprises to produce low-cost drugs However, experts in the industry said that the price reduction of traditional Chinese medicine is almost certain, and the introduction of low-cost drug list is mostly "unreliable" The price reduction is still within the enterprise's tolerance range, according to the Shanghai Securities News on the 13th, a person from the price department of the national development and Reform Commission recently disclosed that in the latest price adjustment of traditional Chinese medicine, the national development and Reform Commission has studied a method different from that of chemical drugs, that is, there is a rise, a fall and a guarantee Among them, most of the prices of traditional Chinese medicine will be lowered, while for some Chinese patent medicines whose prices are less than 5 yuan, as well as some medicines that can no longer guarantee production, the prices will remain stable or even increase It is understood that the direction of price adjustment of Chinese patent medicine has been clear at the beginning of this year At the end of last year, the national development and Reform Commission, together with relevant departments, has conducted a thorough investigation on the planting, production, processing, sales and other aspects of the traditional Chinese medicine industry In the second half of this year, the price reduction plan has been submitted to the relevant departments after various argumentation An expert close to the national development and Reform Commission also confirmed this to reporters The expert said that the price reduction of traditional Chinese medicine in the year is almost a foregone conclusion, but the reduction should be small, with the possible adjustment range of 10% to 20% Due to the rapid rise in the price of traditional Chinese medicine in recent years and the high cost of enterprises, this round of price reduction is more just "meaning" "The profits of traditional Chinese medicine enterprises are considerable, and the price reduction is still within the range that enterprises can bear, especially for large enterprises." It is expected to establish an international drug price database In addition to the rumors about the price reduction of traditional Chinese medicine, it was also reported yesterday that in order to encourage enterprises to produce cheap drugs, the national development and Reform Commission has made new progress in the development of low-cost drug catalogue According to the wechat public group, the draft of the notice of the national development and Reform Commission on improving the management of low-cost drug prices (Draft for comments) has been drafted, and the industry judges that the official version of the document should be published before the end of December Along with the notice came a list of 890 low-cost drugs According to people familiar with the matter, the national development and Reform Commission hopes to cancel the original maximum retail price and change the price to be set by the manufacturers within the daily use fee range, which will greatly reduce the disappearance of cheap drugs "Since there is no specific standard for the concept of low-cost drugs, there is little possibility of a low-cost drug catalog The national development and Reform Commission will not change the current drug ceiling policy for a certain type of drug " People inside the State Food and Drug Administration said However, for the drugs of foreign pharmaceutical companies with high prices in the medical insurance catalogue, the NDRC may study the corresponding price policies in the future In the future, the national development and Reform Commission may establish an international drug price monitoring database to compare the prices of the same drugs at home and abroad, providing data support for the next adjustment of the prices of drugs produced by foreign pharmaceutical enterprises, the person said.